NYSE:DGX

Quest Diagnostics (NYSE:DGX) Sees Strong Q2 Performance and Raised Full-Year Outlook

Font: Financial Modeling Prep  • Jul 23, 2026

Market Chart
  • Barclays increased its price target for Quest Diagnostics (NYSE:DGX), indicating potential upside for the stock.
  • The company reported robust second-quarter results with significant revenue growth and strong Adjusted earnings per share (EPS).
  • Quest Diagnostics has raised its full-year financial forecast due to strong demand across all customer channels and successful partnerships.

Quest Diagnostics (NYSE:DGX) is a leading provider of diagnostic information services, offering a wide range of tests to physicians, hospitals, and consumers. The company plays a crucial role in healthcare by providing insights that help in disease prevention, diagnosis, and treatment. Recently, Quest Diagnostics has received positive attention from financial analysts.

On July 23, 2026, Barclays increased its price target for Quest Diagnostics to $250.00 from its previous target of $230.00. A price target is an analyst's projection of a stock's future price. With the stock trading at $227.90 at the time, this new target suggests a potential upside, or increase, of 9.70%.

This optimistic view is supported by the company's strong second-quarter performance. Quest Diagnostics reported a 10.2% year-over-year increase in revenue, reaching $3.04 billion. This growth was driven by a 10% rise in organic revenue, which measures growth from the company's core operations, excluding factors like acquisitions.

The company's profitability also saw a significant boost. Adjusted earnings per share (EPS), which shows the company's profit per share of stock, rose to $3.12, surpassing analyst expectations of $2.83. This performance was fueled by a 13.1% increase in total volume, indicating a higher number of tests being performed.

Due to these strong results, Quest Diagnostics raised its financial forecast for the full year. As highlighted by PR Newswire, the company now expects revenues between $11.95 billion and $12.05 billion. Management attributes the growth to strong demand across all customer channels and successful partnerships, as noted by MarketBeat.

Market Overview
OMH
Ohmyhome Limited
$0.49
14.69%
SXTC
China SXT Pharmaceuticals, Inc.
$0.06
-80.82%
INTC
Intel Corp.
$92.32
-7.89%
BITO
ProShares Bitcoin ETF
$8.70
-0.80%
GSUN
Golden Sun Education Group Limited
$0.22
-37.80%
LBGJ
Li Bang International Corporation Inc. Ordinary Shares
$0.03
-4.17%
TSLL
Direxion Daily TSLA Bull 2X ETF
$7.42
-4.38%
NOK
Nokia Oyj
$9.07
-6.78%
NVDA
NVIDIA Corporation
$206.99
-0.85%
VIVK
Vivakor, Inc.
$2.87
35.38%